Chemotherapy-induced peripheral neuropathy among paediatric oncology patients

Canadian Journal of Neurological Sciences

Volumn 41, Issue 4, 2014, Pages 442-447

  Purser, M J ^a   Johnston, D L ^a,b   McMillan, H J ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLATINUM DERIVATIVE; VINCA ALKALOID; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; ATAXIA; ATAXIC GAIT; BRAIN TUMOR; CANADA; CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY; CHILD; CHILDHOOD CANCER; COHORT ANALYSIS; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; LIMB DYSESTHESIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; PAIN; PARESTHESIA; PERIPHERAL NEUROPATHY; PERONEUS NERVE PARALYSIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; WEAKNESS; CHEMICALLY INDUCED; FOLLOW UP; NEOPLASMS; ONCOLOGY; ONTARIO; PERIPHERAL NERVOUS SYSTEM DISEASES;

ANTINEOPLASTIC AGENTS; CHILD; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICAL ONCOLOGY; NEOPLASMS; ONTARIO; PERIPHERAL NERVOUS SYSTEM DISEASES; RETROSPECTIVE STUDIES;

EID: 84901765182     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100018461     Document Type: Article

References (18)

1. Gilchrist L. Chemotherapy-induced peripheral neuropathy in pediatric cancer patients. Semin pediatr neurol. 2012;19(1): 9-17.
2. Aytac S, Yetgin S, Tavil B. Acute and long-term neurologic complications in children with acute lymphoblastic leukemia. Turk J pediatr. 2006;48(1):1-7. (Pubitemid 43349479)
3. Renbarger JL, McCammack KC, Rouse CE, Hall SD. Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients. Pediatr blood Cancer. 2008;50 (4):769-71. (Pubitemid 351354782)
4. Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer. 2008;44(11):1507-15.
5. Pal PK. Clinical and electrophysiological studies in vincristine induced neuropathy. Electromyogr Clin neurophysiol. 1999;39 (6):323-30. (Pubitemid 29425922)
6. Egbelakin A, Ferguson MJ, Macgill EA, et al. Increased risk of vincristine neurotoxicity associated with low Cyp3a5 expression genotype in children with acute lymphoblastic leukemia. Pediatr blood Cancer. 2011;56(3):361-7.
7. Verstappen CC, Koeppen S, Heimans JJ, et al. Dose-related vincristine-induced peripheral neuropathy with unexpected offtherapy worsening. Neurology. 2005;64(6):1076-7. (Pubitemid 40388469)
8. Hartman A, Van den Bos C, Stijnen T, Pieters R. Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristine. Cancer. 2006;106(6):1395-401. (Pubitemid 43363920)
9. U.S. Department of health and human Services [homepage on the internet]. Common terminology Criteria for adverse events (CtCae) version 4.0 [updated 2010 June 14; cited 2013 Sep 17]. Available from: http://evs.nci.nih.gov/ftp1/CtCae/ CtCae-4.03-2010-06-14-quickreference-8.5x11.pdf
10. Casey EB, Jellife AM, Le quesne PM, Millett YL. Vincristine neuropathy. Clinical and electrophysiological observations. Brain. 1973;96(1):69-86.
11. Sghirlanzoni A, Silvani A, Scaioli V, Pareyson D, Marchesan R, Boiardi A. Cisplatin neuropathy in brain tumor chemotherapy. Ital J neurol Sci. 1992;13(4):311-15.
12. Van den Berg HW, Desai ZR, Wilson R, Kennedy G, Bridges JM, Shanks RG. The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination. Cancer Chemother pharmacol. 1982;8(2):215-19. (Pubitemid 12081392)
13. Gidding CE, Meeuwsen-de Boer GJ, Koopmans P, Uges DR, Kamps WA, De Graaf SS. Vincristine pharmacokinetics after repetitive dosing in children. Cancer Chemother pharmacol. 1999;44(3):203-9. (Pubitemid 29350175)
14. Anghelescu DL, Faughnan LG, Jeha S, et al. Neuropathic pain during treatment for childhood acute lymphoblastic leukemia. Pediatr blood Cancer. 2011;57(7):1147-53.
15. Reinders-Messelink HA, Van Weerden TW, Fock JM, et al. Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia. Eur J paediatr neurol. 2000;4(5): 225-33.
16. Chauvenet AR, Shashi V, Selsky C, Morgan E, Kurtzberg J, Bell B. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a pediatric oncology group study. J pediatr hematol oncol. 2003; 25(4):316-20. (Pubitemid 36506220)
17. Ness KK, Hudson MM, Pui CH, et al. Neuromuscular impairments in adult survivors of childhood acute lymphoblastic leukemia: associations with physical performance and chemotherapy doses. Cancer. 2012;118(3):828-38.
18. Lehtinen SS, Huuskonen UE, Harila-Saari AH, Tolonen U, Vainionpaa LK, Lanning BM. Motor nervous system impairment persists in long-term survivors of childhood acute lymphoblastic leukemia. Cancer. 2002;94(9):2466-73. (Pubitemid 34457129)